Insider Transactions in Q4 2025 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2025
|
Paige Mahaney Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,644
-5.38%
|
$11,288
$2.58 P/Share
|
|
Oct 28
2025
|
Paige Mahaney Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,200
+15.46%
|
-
|
|
Oct 01
2025
|
Donna Roy Grogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,740
+10.31%
|
$13,480
$2.15 P/Share
|
|
Oct 01
2025
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,349
+3.67%
|
$10,698
$2.15 P/Share
|